BNET Industries
Natus Medical Inc. (BABY) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $118.3M
- Profit
- Dec 31 2007
- $160.0M
- Market Cap
- Oct 10 2008
- $512.7M
Latest News and Analysis
Natus Medical, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions And your first question is from the line of Erik Schneider, UBS Securities. Erik Schneider – UBS Securities Good morning, gentlemen. Just a quick question for Steve on the gross margin side you laid out the Excel-Tech drag on margins, and higher...
Six Ways to Profit from the Mini-Baby Boom
Option Dragon submits: Population growth is the lifeblood of all civilizations and societies. It is a carried promise of further development and prosperity in a nation. The U.S. is in fact in the midst of a mini baby boom and there are long term opportunities here for the looking. A...
Natus Medical, Inc.: Go baby go!
Everyone loves babies, including Natus Medical, Inc. BABY. Find out why Wall Street is going gah-gah over this company.
Natus Medical Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions And your first question comes from Eli Kammerman of Cowen and Company. Please proceed, sir. Eli Kammerman – Cowen & Co. Yes. Thank you and good morning. I've got a couple of questions on neurology, to start. Firstly, you told us...
Additional Resources
PHC, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Your first question comes from [Alim Talmud] – Boston Partners. Alim Talmud – Boston Partners First of all, you’ve got Detroit and Seven Hills and Seven Hills should incrementally add over $12 million , $12 millionish. Then Detroit should add something,...
Healthcare Usage Drops Due to Costs, Economic Woes
Medical care doesn't sound like one of those things consumers would skimp on when times get tough. Yet signs are mounting that patients are in fact delaying or skipping on treatment as a result of higher costs and concerns over the economic downturn against the backdrop of the financial crisis....
Healthcare Roundup: Fed Step Into McKesson Case, WellCare Implicated in Medicaid Fraud, and More
Feds intervene in McKesson whistleblower case -- The Justice Department has stepped into a private whistleblower lawsuit against medical-product supplier McKesson. The suit alleges that McKesson and nursing-home operator Golden Living defrauded Medicare through a sham supplier of durable medical equipment. [Source: Modern Healthcare] WellCare employee pleads...
China Medical Expands In Vitro Lineup with Virus Diagnostic Test
ChinaBio Today submits: China Medical Technologies CMED, which produces in-vitro diagnostic products, will pay $345 million to purchase the rights for a human papillomavirus (HPV) test from Molecular Diagnostics Technologies Limited. China Medical will buy the HPV-DNA Biosensor Chip and Surface Plasmon Resonance-based Analysis System the SPR System, which...
CFOs Still Predicting Healthy Financial Results
CFOs Still Predicting Healthy Financial ResultsRE: CFOs Still Predicting Healthy Financial ResultsHello, I'm Neill Newton - CEO - Global Flying Hospitals. (GFHosp@gmail.com). Today, we see panic everywhere, and this has triggered fear in people. Uncertain times ahead ... batten down the hatches, gird your loins, run for cover...
Cantel Medical Corp. F4Q08 (Qtr End 07/31/08) Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions The first question comes from Michael Gaugler- Brean Murray, Carret & Company. Michael Gaugler- Brean Murray, Carret & Company Andy let’s start with the dialysis business for a moment. When I think back to some of the previous calls and discussions the...
Healthcare Roundup: Revolution Health Vanishes, Cardinal Health Penalized, and More
Revolution Health merges with Waterfront Media in $300M deal -- So the rumors were true. Steve Case's once-flashy startup, Revolution Health Network, agreed last week to merge with Waterfront Media, owner of several online-health Web sites, in a $300 million deal. Case will continue to run Revolution LLC, which will...
Q&A With Medicis CEO Jonah Shacknai, Who Sees a "Definite Downturn" in Vanity Pharma
Medicis is going through a dramatic period. The vanity pharma company's Restylane dermal filler is in a battle royale with Allergan's Juvederm. It's waiting for FDA approval for Reloxin, its competitor to Allergan's Botox. And it just acquired LipoSonix, a high-intensity non-invasive ultrasound fat reducer. I talked...
GSI Group: Promising Value Play
Barel Karsan submits: Benjamin Graham wrote about "net-net value plays" as situations where a company's current assets minus all liabilities the result is called net current asset value or NCAV is worth more than the current market capitalization of the stock. If the value of current assets is accurately...
Academic Drug Conflicts Probe: "Problems With Transparency Are Everywhere"
Emory. Harvard. Stanford. Brown. The University of Texas. The University of Cincinnati. It's a roll call of the nation's most prominent schools of psychiatry. But top researchers and professors at those schools could, essentially, be rented out by drug companies for hundreds of thousands of dollars. Then, those academics allegedly...
Drug Companies' Health Education Campaigns No Longer Speak Spanish
Drug Companies' Health Education Campaigns No Longer Speak SpanishRE: Drug Companies' Health Education Campaigns No Longer Speak SpanishWow, it's bad enough the Hispanic community isn't getting the best medical coverage and care that they need, but now we are not able to see health ads in Spanish. We are really...
Filtrona to Buy Lendell
LONDON (Reuters UK) - Plastics and fibre products firm Filtrona FLTR said on Friday it is to acquire U.S. foam products company Lendell Manufacturing for $35 million (19.8 million pounds).Michigan-based Lendell, which produces foam products for the medical, printing and cosmetics markets, has 55 percent of its business in the...
United Drug Says Year Profit Hits Target
DUBLIN (Reuters UK) - United Drug UDG said on Friday its results for the year just ended would be in line with its forecast of a double-digit percentage rise in profit and it remained positive for its core markets, despite challenges."Operating profit and earnings for the year (to September 30)...
Healthcare Roundup: Stent Makers Pay Up, New York Pays Hospitals to Close, and More
Stent makers forced to pay J&J $1.2B -- Medtronic and Boston Scientific lost separate patent-infringement cases regarding their bare-metal stents to Johnson & Johnson, and now owe J&J $521 million and $703 million, respectively. Oddly enough, Boston Scientific pulled the offending blood-vessel scaffolds from the market four years ago. [Source:...
BNET Focus on Antidepressants: Part 2, Controversies
BNET Focus on Antidepressants: Part 2, ControversiesRE: BNET Focus on Antidepressants: Part 2, ControversiesLilly responds: Dear Jim,I am writing to you regarding your article, "Focus on Antidepressants: Part 2, Controversies," posted yesterday (10/1) on Bnet.com, in which two facts were inaccurately reported on Lilly's practices around funding of the NPR...
Healthcare Roundup: Wal-Mart Offers Employee PHRs, Health Plan Collapses, and More
Wal-Mart offers employees personal-health records -- The retail giant said it would offer its employees electronic PHRs based on technology from WebMD and Dossia, an employer coalition. The company will pre-fill those records with prescription-drug and medical-treatment information from pharmacies and health-insurance companies. Of course, there's a catch: The plan...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
- Incorporated: 1987
- CEO: Mr. James B. Hawkins
Natus Medical is a provider of healthcare products used for screening, detection, treatment, monitoring and tracking of medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Co.'s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.
Key Competitors
Natus Medical Inc. Company Info
Board of Directors
Mr. Robert A. Gunst
Chairman
Mr. Kenneth E. Ludlum
Mr. Mark D. Michael
Ms. Doris E. Engibous
Mr. James B. Hawkins
Mr. William M. Moore
Contact Information
1501 Industrial Road
San Carlos, CA
650 802-0400